SynapseMed

About the Product

SynapseMed empowers radiologists and pathologists with robust AI-driven image analysis. Their platform drastically improves the accuracy and speed of detecting anomalies, such as early-stage tumors and micro-fractures, in MRI and CT scans.

By integrating directly into existing hospital PACS networks, it acts as a silent second opinion, prioritizing high-risk patient scans for immediate doctor review.

Core Technology & AI Stack

• Architecture 3D Convolutional Neural Networks (CNNs)
• Models Custom Medical Imaging Segmentation Models
• Infrastructure HIPAA/GDPR Compliant Healthcare Cloud

Company Intelligence

• Founded 2021
• Status Active
• Funding Stage Series A (€12M)
• Lead Investor HealthTech Europe VC
• Team Size 30-60

Founding Team